Where does checkpoint collide?

In database and transaction-processing systems, a checkpoint is a moment at which the system writes a consistent marker and flushes enough state to stable storage so that, after a crash, recovery can begin from the checkpoint rather than replaying the entire log from the beginning. Haerder and Reuter's 1983 Principles of transaction-oriented database recovery classified checkpointing schemes and showed how they bound the work a restart must redo or undo. The referent is a recovery optimization in a write-ahead-logging system, measured by how much log a restart must re-read, not a phase gate in the cell cycle or a brake on the immune system.[1]

Unit

The log position from which crash recovery can safely begin

Recovery means

After a crash, restart redoes and undoes only work recorded after the last checkpoint, then resumes normal processing

Measured by

Judged by the bounded amount of log re-read and the pages reprocessed during restart

In cell biology, a checkpoint is a surveillance control that halts progression through the cell cycle until prerequisite events are complete and error-free (for example, pausing before mitosis until DNA is fully replicated and undamaged). Hartwell and Weinert's 1989 Checkpoints: controls that ensure the order of cell cycle events introduced the term and the idea of dependency enforced by feedback rather than by the intrinsic timing of reactions. The referent is a regulatory gate in cell-cycle progression, assayed by arrest and resumption of division, and distinct from a database recovery marker or an immune off-switch.[2]

Unit

The arrest point gating a transition between cell-cycle phases

Recovery means

When the monitored condition is satisfied, the checkpoint releases and the cycle proceeds

Measured by

Detected by cell-cycle arrest, checkpoint-protein activity, and resumption of division once the defect is resolved

In immunology, an immune checkpoint is an inhibitory receptor–ligand pathway (such as CTLA-4 or PD-1) that dampens T-cell activation to protect healthy tissue from autoimmune attack; tumours exploit these brakes to evade immune killing, which is why checkpoint-blockade drugs work by releasing them. Pardoll's 2012 The blockade of immune checkpoints in cancer immunotherapy reviews these pathways and the therapeutic logic of inhibiting them. The referent is a molecular brake on the adaptive immune response, measured by receptor signalling and T-cell activity, unrelated to a cell-cycle gate or a database restart marker beyond the shared word.[3]

Unit

The strength of the inhibitory signal restraining T-cell activation

Recovery means

Not applicable

Measured by

Quantified by checkpoint-receptor expression, ligand engagement, and T-cell responses after blockade